saikosaponin d has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, M; Duan, S; Fan, G; Gu, Y; Li, X; Li, Y; Liu, C; Liu, R; Sun, R; Zheng, Q | 1 |
| Feng, S; Han, H; Shi, M; Tang, J; Wang, L; Zhang, T | 1 |
2 other study(ies) available for saikosaponin d and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARĪ± and INSIG/SREBP1c pathway.
Topics: Animals; Diet, High-Fat; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleanolic Acid; PPAR alpha; Saponins; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2022 |
Study on the mechanism of Shuganzhi Tablet against nonalcoholic fatty liver disease and lipid regulation effects of its main substances in vitro.
Topics: Animals; Cholesterol; Diet, High-Fat; Emodin; Hesperidin; Lipid Metabolism; Lipids; Liver; Non-alcoholic Fatty Liver Disease; PPAR gamma; Rats; Resveratrol | 2023 |